2006
DOI: 10.1016/j.bmc.2006.01.016
|View full text |Cite
|
Sign up to set email alerts
|

Antifungal properties of new series of quinoline derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
150
2
4

Year Published

2008
2008
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 272 publications
(162 citation statements)
references
References 15 publications
3
150
2
4
Order By: Relevance
“…[1][2][3] The structural core of quinoline is often found in more complex natural products 4 and is frequently associated with biological activity, such as anticancer, 5 antifungal, 6 HIV-1 integrase inhibitors, 7 HIV protease inhibitors 8 antileishmanial activity, 9 NK-3 receptor antagonists 10 and pLT antagonists. [11][12][13] Our objectives were to synthesize a series of quinoline derivatives substituted at position 1 and 2 by a spacer linked with a series of amino acids and dipeptides as pLT antagonists regarded as important mediators of human bronchial asthma 14 .…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3] The structural core of quinoline is often found in more complex natural products 4 and is frequently associated with biological activity, such as anticancer, 5 antifungal, 6 HIV-1 integrase inhibitors, 7 HIV protease inhibitors 8 antileishmanial activity, 9 NK-3 receptor antagonists 10 and pLT antagonists. [11][12][13] Our objectives were to synthesize a series of quinoline derivatives substituted at position 1 and 2 by a spacer linked with a series of amino acids and dipeptides as pLT antagonists regarded as important mediators of human bronchial asthma 14 .…”
Section: Introductionmentioning
confidence: 99%
“…For background information on the pharmacological activity of quinoline derivatives, see: Elslager et al (1969); Font et al (1997); Kaminsky & Meltzer (1968); Musiol et al (2006); Nakamura et al (1999); Palmer et al (1993); Ridley (2002); Sloboda et al (1991); Tanenbaum & Tuffanelli (1980); Warshakoon et al (2006). For recent studies on quinoline-based anti-malarials, see: Andrade et al (2007); Cunico et al (2006); da Silva et al (2003); de Souza et al (2005).…”
Section: Related Literaturementioning
confidence: 99%
“…The majority of drugs used against malaria, such as chloroquine (Tanenbaum & Tuffanelli, 1980), mefloquine (Palmer et al, 1993), primaquine (Elslager et al, 1969) and amodiaquine (Ridley, 2002) possess a quinoline ring which has been the mainstay of malaria chemotherapy for much of the past 40 years (Font et al, 1997;Kaminsky & Meltzer, 1968;Musiol et al, 2006;Nakamura et al, 1999;Sloboda et al, 1991;Warshakoon et al, 2006). However, their effectiveness has been seriously eroded in recent years, mainly as a result of the development of parasite resistance (Ridley, 2002).…”
Section: S1 Commentmentioning
confidence: 99%
“…A quinoline scaffold possesses unique physico-chemical properties and therefore it is present in many classes of biologically-active compounds expressing diverse effects [1][2][3][4][5][6]. In addition, according to the results reported recently, some quinoline derivatives and their analogues/isosteres also showed noteworthy herbicidal activities [7][8][9][10][11][12][13][14][15][16][17][18][19][20].…”
Section: Introductionmentioning
confidence: 99%